Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a minor refresh of the Study Details page. This change updates the revision history without altering the study content or terms.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.6.5 was added to the page's revision history, replacing the previous v3.6.4.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the study record published with minor edits.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.0, indicating a new page revision or metadata update rather than a change to study details.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now indicates that recruitment has ended for the study, meaning participants can no longer enroll. It also adds new help and guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label from v3.5.5 to v3.6.0, with a minor formatting tweak to the Intervention/Treatment label.SummaryDifference0.5%

- Check99 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study details, outcomes, or eligibility criteria appear to have been changed.SummaryDifference0.1%

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.